Efficacy and safety of topical ruxolitinib cream for the treatment of vitiligo: A systematic review and meta-analysis of randomized controlled trials

J Cosmet Dermatol. 2024 Jan;23(1):350-353. doi: 10.1111/jocd.15921. Epub 2023 Jul 5.

Authors

Affiliations

¹ Department of Dermatology, King Edward Medical University, Lahore, Pakistan.
² Department of Medicine, King Edward Medical University, Lahore, Pakistan.
³ Department of Internal Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
⁴ Department of Internal Medicine, Limerick University Hospital, Limerick, Ireland.
⁵ Hamad Medical Corporation, Doha, Qatar.

PMID: 38161317
DOI: 10.1111/jocd.15921

No abstract available

Keywords: F-VASI50; F-VASI75; meta-analysis; ruxolitinib; vitiligo.

Publication types

Meta-Analysis
Systematic Review
Letter

MeSH terms

Humans
Nitriles* / adverse effects
Pyrazoles* / adverse effects
Pyrimidines* / adverse effects
Randomized Controlled Trials as Topic
Treatment Outcome
Vitiligo* / drug therapy

Substances

Nitriles
Pyrimidines
ruxolitinib
Pyrazoles